Menu

Federal Ban Lifted on Studying Most Dangerous Pathogens

Only a few labs will earn funding for such “gain-of-function” research on SARS, MERS, and other deadly diseases.

Dec 20, 2017
Kerry Grens

WIKIMEDIA, THE US FOOD AND DRUG ADMINISTRATIONAs of Tuesday (December 19), the US government has ended its moratorium on funding “gain-of-function” research on deadly pathogens. These studies allow for the manipulation of potentially pandemic-causing viruses.

According to The Washington Post, National Institutes of Health Director Francis Collins told reporters that the government has developed a new, stringent policy outlining the justifications necessary for such risky investigations to receive money. “This kind of research can only be conducted in a very few places that have the highest level of containment,” Collins said.

The ban emerged in 2014 after a series of concerning events. In 2012, researchers had developed an influenza virus that ferrets could catch through the air. Then in 2014, biosafety mishaps shook up federal agencies—one involved staff being exposed to anthrax, another with forgotten vials of smallpox that were discovered in a storage facility.

The ban’s end “is very good news for laboratories interested in understanding the threat of natural pathogens to the human population,” James Paulson, a researcher at The Scripps Research Institute, tells NPR.

But the scientific community is not in complete agreement that gain-of-function studies are warranted. Marc Lipsitch, an epidemiologist at the Harvard T.H. Chan School of Public Health tells Nature that such studies “have done almost nothing to improve our preparedness for pandemics—yet they risked creating an accidental pandemic.” 

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing